Real-World Data on Treatment Choices for mccRCC
Diabetes and CKD: Strategies for Diagnosis and Treatment
Trimethylamine N-Oxide and CKD: A Concerning Link
David J. Maron, MD
PeerMarc P. Bonaca, MD, MPH
PeerDeepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
PeerMatthew Jay Budoff, MD
PeerIgAN Insights: The Potential Role of the Complement System in Disease Progression
Jean Francis, MD
PeerIdentifying Patients at High-Risk for IgAN Progression: Key Factors to Know
How the HIF Pathway Orchestrates an Adaptive, Physiological Response to Anemia
Advancing the Science of Anemia Due to CKD
The Pathophysiology of Anemia of CKD
Steven Fishbane, MD
PeerThe Current Standard of Care and Unmet Need in Anemia of CKD
Sophia Ambruso, DO
Peer